Keyword

VISION trial

Description: A randomized clinical trial evaluating lutetium-177–PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
OpenAlex ID: keywords/vision-trial
2006 · EUGENE W.M. NG, ANTHONY P. ADAMIS · Annals of the New York Academy of Sciences · 170
2022 · Susan J. Keam · Molecular Diagnosis & Therapy · 107
2023 · Albert Jang, Ayse T. Kendi, et al. · Therapeutic Advances in Medical Oncology · 104
2021 · Michael J. Morris, Johann S. De Bono, et al. · Journal of Clinical Oncology · 88
2022 · Ken Herrmann, Luca Giovanella, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 86
2023 · Brian Ramnaraign, Oliver Sartor · The Oncologist · 79
2021 · Leylah M. Drusbosky, Richa Dawar, et al. · Journal of Hematology & Oncology · 69
2022 · Phillip H. Kuo, Taylor Benson, et al. · Journal of Nuclear Medicine · 57
2022 · Andrei Gafita, Charles Marcus, et al. · American Society of Clinical Oncology Educational Book · 55
2023 · Dirk Mehrens, Kristina K.M. Kramer, et al. · Journal of the National Comprehensive Cancer Network · 47
2021 · Xiuning Le, Luis G. Paz-Ares, et al. · Journal of Clinical Oncology · 47
Works count: 299
Citation count: 3,827
Year
Topic
Type